Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
This study is ongoing, but not recruiting participants.
Study NCT00005787 Information provided by National Cancer Institute (NCI)
First Received: June 2, 2000 Last Updated: May 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma
Neutropenia
Additional conditions recognized in this trial
Lymphoma, Non-Hodgkin
More general conditions related to this trial
Agranulocytosis
Hematologic Diseases
Immune System Diseases
Immunoproliferative Disorders
Leukocyte Disorders
Leukopenia
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
epoetin alfa
filgrastim
recombinant flt3 ligand
recombinant interleukin-3
sargramostim
Additional drug interventions recognized in this trial
Flt3 ligand protein
More general drug interventions related to this trial
Adjuvants, Immunologic
Hematinics
Hematologic Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Robert H. Lurie Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content